
NimBio
NimBio develops non-invasive diagnostic tools for early disease detection using advanced biosensing.
About
NimBio offers a proactive care solution for Inflammatory Bowel Disease (IBD) patients through its Inflammometer™ platform, which uses passive biosensing for real-time inflammation monitoring and early flare detection. This platform aims to provide effortless, remote, and personalized care for patients, while enhancing care delivery for hospitals and physicians, optimizing treatment for pharma, and reducing hospitalizations for payers. NimBio's solution focuses on identifying flare causes and offering therapeutic recommendations to prevent complications and optimize IBD management.
Listed competitors
Show 6 more similar companies
Also in this space
Revolutionizing electrophysiology with innovative, wireless, wearable Smart Skin technology for advanced monitoring.
Shares Healthcare, Biotech
Bioelectric medicine company advancing neurorecovery for stroke and neurological conditions.
Shares Healthcare, Biotech
Nucleix is a liquid biopsy company developing early cancer detection solutions using methylation analysis.
Shares Healthcare, Non-invasive
Neurolief develops proprietary digital therapeutics neuromodulation technology to treat neurological and neuropsychiatric disorders like migraine and depression.
Shares Healthcare, Wearables
Develops a continuous, non-invasive arterial pressure monitoring device for cardiovascular disease management.
Shares Healthcare, Non-invasive
Cnoga Medical develops and manufactures non-invasive, pain-free medical devices for personal and professional remote medical care.
Shares Healthcare, Non-invasive
Signals agent
Reach companies that have budget right now
Every week the agent finds companies in your market that just got money or started hiring to spend it, and the person to talk to. You choose who to reach; nothing is sent for you.
- Just raised a roundFresh budget, the week it lands
- Hiring sales and marketingGo-to-market roles mean money to spend
- Hiring fastA jump in open roles across the company
- In the newsLaunches and announcements worth a message
- The decision makerWho to contact, with a message you can edit
Is your startup an alternative to NimBio?
People comparing tools land here. Get listed beside these.
Copy NimBio's SEO strategy
How often they publish, which searches their posts chase and their newest posts. Then outrank them.
All funding rounds
Key facts
- Website
- nimbio.ai
- Headquarters
- San Francisco, United States
- Founded
- 2019
- Founder
- Tal Atarot
- Employees
- 5
- Business model
- B2B
Funding rounds
- Undisclosed7 Dec 2022
Led by eHealth Ventures
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 7 Dec 2022 | Pre-Seed | Undisclosed | eHealth Ventures |
Tech stack
Detected on nimbio.ai, last scanned 22 Nov 2026. Run your own scan
- Email provider
- Google Workspace
Benchmarking
See how your site ranks against 16,849 startups
NimBio sits in the 12th percentile for Domain Rating. Check where yours lands, free.
NimBio has a Domain Rating of 7, the 12th percentile of 16,849 startups we track.
Measured, not editorial
Ahrefs DR
Bottom 25%
Check yoursAgent Readiness
Bottom 25%
Scan yoursSecurity
Click to scan
Agent Readiness
Can AI agents use your site?
NimBio scores 28. Check yours free in a few seconds, or let Max Agent rerun it daily.
Run it daily with Max AgentGet notified when NimBio changes
Used NimBio? Write a review and get $5 in credits
Your first review on StartupHub.ai adds 1,250 credits to your account. Spend them on:
- Email finder
- Market Map Maker
- Agent Readiness scans
- Deep intel
- Tech stack scans
Frequently asked
Who owns NimBio?
NimBio is privately held, owned by its founders and investors. Investors on record include eHealth Ventures. Exact stakes are not public.
Are there companies like NimBio?
Yes. We list 7 companies like NimBio, including Kinsa, X-trodes and BrainQ.
How many employees does NimBio have?
NimBio has approximately 5 people on record.
SEC filings, insider activity, nonprofit links and pay benchmarks for NimBio:
Company details: from public sources. Funding: 1 round on file. Ownership: not yet claimed by the company. Scores: measured by named tools; each links to its method. Our rules
Categories
Max Agent
Let Max Agent watch NimBio and its market for you
New competitors, funding rounds, pricing and product changes, and where you show up in AI answers, in one weekly report.
Free week
Starter listings, once
AI answers checked
Daily for 7 days
ChatGPT
Perplexity
Max Agent
$79 a month, or $9.99 with our badge on your site
AI answers checked
Every week
ChatGPT
Claude
Perplexity
Gemini

